Co-Diagnostics

$9.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.23 (+2.41%) As of 4:33 PM UTC today

Why Robinhood?

You can buy or sell Co-Diagnostics and other stocks, options, and ETFs commission-free!

About CODX

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

CEO
Dwight Howard Egan
Employees
37
Headquarters
Salt Lake City, Utah
Founded
2013
Market Cap
296.31M
Price-Earnings Ratio
5.79
Dividend Yield
—
Average Volume
1.47M
High Today
$9.87
Low Today
$9.37
Open Price
$9.38
Volume
413.07K
52 Week High
$30.99
52 Week Low
$7.86

CODX Earnings

-$0.10
$0.14
$0.39
$0.63
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours

You May Also Like

KLCD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure